Patrick Donnelly
Stock Analyst at Citigroup
(3.70)
# 791
Out of 4,667 analysts
303
Total ratings
52.55%
Success rate
6.06%
Average return
Main Sectors:
Stocks Rated by Patrick Donnelly
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| SHC Sotera Health Company | Maintains: Buy | $18 → $20 | $13.61 | +46.95% | 3 | Nov 6, 2024 | |
| BRKR Bruker | Maintains: Buy | $80 → $75 | $48.25 | +55.44% | 14 | Nov 6, 2024 | |
| EXAS Exact Sciences | Maintains: Buy | $80 → $75 | $53.92 | +39.09% | 13 | Nov 6, 2024 | |
| ILMN Illumina | Maintains: Buy | $155 → $190 | $135.00 | +40.74% | 13 | Nov 5, 2024 | |
| BIO Bio-Rad Laboratories | Maintains: Buy | $400 → $450 | $320.66 | +40.34% | 14 | Oct 31, 2024 | |
| BIO.B Bio-Rad Laboratories | Maintains: Buy | $400 → $450 | $334.85 | +34.39% | 14 | Oct 31, 2024 | |
| TXG 10x Genomics | Maintains: Buy | $35 → $23 | $13.57 | +69.49% | 10 | Oct 30, 2024 | |
| DGX Quest Diagnostics | Maintains: Buy | $165 → $185 | $161.16 | +14.79% | 10 | Oct 23, 2024 | |
| HOLX Hologic | Downgrades: Neutral | $95 → $85 | $78.57 | +8.18% | 13 | Oct 1, 2024 | |
| CRL Charles River Laboratories International | Downgrades: Sell | $215 → $175 | $186.10 | -5.96% | 19 | Oct 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $150 → $165 | $125.69 | +31.28% | 26 | Aug 22, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $42 → $30 | $18.68 | +60.60% | 3 | Aug 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $40 → $45 | $30.68 | +46.68% | 9 | Aug 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $30 → $28 | $18.15 | +54.27% | 4 | Aug 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $135 → $145 | $109.91 | +31.93% | 1 | Jul 30, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $30 → $23 | $19.72 | +16.63% | 7 | Jul 10, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $85 | $66.37 | +28.07% | 10 | May 22, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Sell | $975 → $1,200 | $1,160.67 | +3.39% | 10 | May 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $280 → $290 | $230.84 | +25.63% | 10 | Apr 24, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reinstates: Neutral | $620 | $509.12 | +21.78% | 17 | Mar 18, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $62 → $60 | $40.80 | +47.06% | 13 | Feb 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $265 → $300 | $344.71 | -12.97% | 24 | Dec 11, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $95 → $72 | $38.58 | +86.63% | 3 | Dec 11, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $7 → $9 | $3.86 | +133.16% | 6 | Dec 11, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $190 → $225 | $191.33 | +17.60% | 9 | Dec 11, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $300 → $315 | $195.60 | +61.04% | 7 | Dec 11, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $3.75 → $2.75 | $6.18 | -55.50% | 4 | Aug 10, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $250 → $260 | $236.23 | +10.06% | 11 | Feb 17, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $8 → $6 | $3.69 | +62.60% | 4 | Nov 3, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Neutral | $28 → $32 | $15.00 | +113.33% | 2 | Nov 30, 2018 |
Sotera Health Company
Nov 6, 2024
Maintains: Buy
Price Target: $18 → $20
Current: $13.61
Upside: +46.95%
Bruker
Nov 6, 2024
Maintains: Buy
Price Target: $80 → $75
Current: $48.25
Upside: +55.44%
Exact Sciences
Nov 6, 2024
Maintains: Buy
Price Target: $80 → $75
Current: $53.92
Upside: +39.09%
Illumina
Nov 5, 2024
Maintains: Buy
Price Target: $155 → $190
Current: $135.00
Upside: +40.74%
Bio-Rad Laboratories
Oct 31, 2024
Maintains: Buy
Price Target: $400 → $450
Current: $320.66
Upside: +40.34%
Bio-Rad Laboratories
Oct 31, 2024
Maintains: Buy
Price Target: $400 → $450
Current: $334.85
Upside: +34.39%
10x Genomics
Oct 30, 2024
Maintains: Buy
Price Target: $35 → $23
Current: $13.57
Upside: +69.49%
Quest Diagnostics
Oct 23, 2024
Maintains: Buy
Price Target: $165 → $185
Current: $161.16
Upside: +14.79%
Hologic
Oct 1, 2024
Downgrades: Neutral
Price Target: $95 → $85
Current: $78.57
Upside: +8.18%
Charles River Laboratories International
Oct 1, 2024
Downgrades: Sell
Price Target: $215 → $175
Current: $186.10
Upside: -5.96%
Aug 22, 2024
Maintains: Buy
Price Target: $150 → $165
Current: $125.69
Upside: +31.28%
Aug 13, 2024
Maintains: Buy
Price Target: $42 → $30
Current: $18.68
Upside: +60.60%
Aug 8, 2024
Maintains: Buy
Price Target: $40 → $45
Current: $30.68
Upside: +46.68%
Aug 7, 2024
Maintains: Buy
Price Target: $30 → $28
Current: $18.15
Upside: +54.27%
Jul 30, 2024
Maintains: Buy
Price Target: $135 → $145
Current: $109.91
Upside: +31.93%
Jul 10, 2024
Downgrades: Neutral
Price Target: $30 → $23
Current: $19.72
Upside: +16.63%
May 22, 2024
Downgrades: Neutral
Price Target: $85
Current: $66.37
Upside: +28.07%
May 13, 2024
Maintains: Sell
Price Target: $975 → $1,200
Current: $1,160.67
Upside: +3.39%
Apr 24, 2024
Maintains: Buy
Price Target: $280 → $290
Current: $230.84
Upside: +25.63%
Mar 18, 2024
Reinstates: Neutral
Price Target: $620
Current: $509.12
Upside: +21.78%
Feb 8, 2024
Maintains: Buy
Price Target: $62 → $60
Current: $40.80
Upside: +47.06%
Dec 11, 2023
Maintains: Neutral
Price Target: $265 → $300
Current: $344.71
Upside: -12.97%
Dec 11, 2023
Downgrades: Neutral
Price Target: $95 → $72
Current: $38.58
Upside: +86.63%
Dec 11, 2023
Maintains: Buy
Price Target: $7 → $9
Current: $3.86
Upside: +133.16%
Dec 11, 2023
Maintains: Neutral
Price Target: $190 → $225
Current: $191.33
Upside: +17.60%
Dec 11, 2023
Maintains: Buy
Price Target: $300 → $315
Current: $195.60
Upside: +61.04%
Aug 10, 2023
Maintains: Neutral
Price Target: $3.75 → $2.75
Current: $6.18
Upside: -55.50%
Feb 17, 2023
Maintains: Neutral
Price Target: $250 → $260
Current: $236.23
Upside: +10.06%
Nov 3, 2022
Maintains: Buy
Price Target: $8 → $6
Current: $3.69
Upside: +62.60%
Nov 30, 2018
Upgrades: Neutral
Price Target: $28 → $32
Current: $15.00
Upside: +113.33%